Samsung Biologics
207940.KS
#393
Rank
A$81.59 B
Marketcap
$1,146
Share price
-0.19%
Change (1 day)
20.32%
Change (1 year)

Earnings for Samsung Biologics (207940.KS)

Earnings in 2024 (TTM): A$1.83 Billion

According to Samsung Biologics 's latest financial reports the company's current earnings are A$3.27 Billion. In 2023 the company made an earning of A$1.44 Billion, an increase over its 2022 earnings that were of A$1.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Samsung Biologics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$1.83 B26.52%
2023 A$1.44 B9.77%
2022 A$1.31 B67.66%
2021 A$0.78 B103.97%
2020 A$0.38 B57.39%
2019 A$0.24 B-45.46%
2018 A$0.44 B-390%
2017 -A$0.16 Billion-46.74%
2016 -A$0.3 Billion